We combine advanced neuromodulation with minimally invasive delivery to treat heart failure at its source, increasing cardiac efficiency without major surgery.
The Harmony™ System uses sophisticated RF-powered neurostimulation to modulate the autonomic nervous system, effectively reducing heart rate and decreasing the workload on the left ventricle.
Unlike traditional cardiac surgeries, our system is implanted via a standard catheter-based procedure. This approach minimizes patient trauma, reduces hospital stays, and allows for faster recovery times.
By providing consistent, real-time stimulation, the system stabilizes hemodynamics. Clinical data indicates a significant improvement in cardiac output and overall quality of life for chronic heart failure patients.
A miniaturized, biocompatible pulse generator designed for long-term implantation and precise energy delivery.
RF-Powered: Advanced radio-frequency technology for battery-less or high-efficiency operation.
Titratable Therapy: Adjustable stimulation parameters to meet individual patient needs.
Compact Design: Engineered for minimally invasive placement within the vascular system.
High-fidelity stimulation leads designed to anchor securely and deliver targeted electrical pulses to the autonomic nervous system.
Vascular Fixation: Proprietary anchoring mechanism to prevent lead migration.
Biostable Materials: Built with medical-grade alloys for lifetime durability.
Precision Placement: Designed for optimal contact with neural pathways.
A proprietary, low-profile catheter system that enables the implantation of the Harmony™ System without open-heart surgery.
Standard Access: Compatible with existing femoral or jugular venous access techniques.
Navigational Control: Enhanced torque and flexibility for precise positioning in complex anatomy.
Reduced Trauma: Minimizes procedural risk and accelerates patient recovery times.
Integrated sensors that provide real-time data on the patient’s cardiac response to ensure therapy is optimized.
Real-Time Diagnostics: Continuous monitoring of heart rate and electrical activity.
Closed-Loop Potential: Technology capable of adjusting stimulation based on physiological demand.
Data Integrity: Secure transmission of clinical parameters for physician review.
Our technology is backed by a rigorous manufacturing and tracking system that ensures every component meets life-critical standards.
100% Traceability: Digital records for every device from cleanroom to patient.
ISO Certified: Manufactured under the highest global medical device quality standards.
Scalable Production: Infrastructure ready to support global clinical trials and commercial launch.
We focus on results that matter: significant reduction in heart failure symptoms, improved cardiac efficiency, and long-term stabilization of patient health.
Our clinical trials and production lines are designed with global scalability in mind, supported by a digital ecosystem that ensures 100% device traceability.
We align every technical advancement with real-world clinical needs, ensuring our neuromodulation therapy creates a practical, life-saving impact for heart failure patients.
Subscribe for real-time updates on Harmony™ System clinical trials and news.
